Powder: -20°C for 3 years | In solvent: -80°C for 1 year
R121919 (NBI30775) is a potent small molecule adrenocorticotropic hormone-releasing factor receptor 1 (CRF1) receptor antagonist with antidepressant and anxiolytic activity that inhibits the CRF1 receptor, the CRF2 receptor, and the CRF-binding proteins.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 143.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 488.00 | |
100 mg | In stock | $ 783.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | R121919 (NBI30775) is a potent small molecule adrenocorticotropic hormone-releasing factor receptor 1 (CRF1) receptor antagonist with antidepressant and anxiolytic activity that inhibits the CRF1 receptor, the CRF2 receptor, and the CRF-binding proteins. |
Targets&IC50 | CRF1 receptor:2-5 nM (Ki) |
In vitro | R121919 is a potent small-molecule CRF1 receptor antagonist, exhibiting high affinity for the CRF1 receptor with a Ki value in the range of 2–5 nM. Notably, its activity at the CRF2 receptor, CRF-binding protein, and 70 other receptor types is over 1000-fold weaker[2]. |
In vivo |
In rats, R121919 demonstrates a dose-dependent reduction in adrenocorticotropic hormone and corticosterone responses to restraint stress. At a dose of 10 mg/kg R121919, peak plasma concentrations of adrenocorticotropic hormone and corticosterone are decreased by 9% and 25%, respectively[2]. Moreover, R121919 exhibits anxiolytic effects in mice with a steep dose-response curve, leading to reduced anxiety levels. Some of the intracellular targets of the drug include molecules like GR (glucocorticoid receptor), MR (mineralocorticoid receptor), BAG-1 (Bcl-2-associated athanogene-1), and AP-1 (activator protein 1)[1]. |
Synonyms | NBI30775 |
Molecular Weight | 380.53 |
Formula | C22H32N6 |
CAS No. | 195055-03-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL(13.14 mM), Sonication is recommended.
Ethanol: 80 mg/mL(210.23 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
R121919 195055-03-9 Others R-121919 NBI30775 NBI-30775 R 121919 NBI 30775 inhibitor inhibit